Inhibin α-subunit (INHA) gene and locus changes in paediatric adrenocortical tumours from TP53 R337H mutation heterozygote carriers

Journal of Medical Genetics

Volumn 41, Issue 5, 2004, Pages 354-359

  Longui, C A ^a   Lemos Marini, S H V ^b   Figueiredo, B ^c   Mendonca, B B ^d   Castro, M ^d   Liberatore Jr , R ^e   Watanabe, C ^f   Lancellotti, C L P ^a   Rocha, M N ^a   Melo, M B ^a   Monte, O ^a   Calliari, L E P ^a   Guerra Jr , G ^b   Baptista, M T M ^b   Sbragia Neto, L ^b   Latronico, A C ^d   Moreira, A ^d   Tardelli, A M D ^f   Nigri, A ^f   Taymans, S E ^g   Stratakis, C A ^g   more..

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e Institute of Biomedicine   (Brazil)

^f UNIVERSITY OF SOROCABA   (Brazil)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA;

ADRENAL CORTEX TUMOR; ALPHA CHAIN; AMINO ACID SUBSTITUTION; ARTICLE; BRAZIL; CARCINOGENESIS; CLINICAL ARTICLE; DNA FLANKING REGION; EXON; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GERM LINE; HETEROZYGOTE; HUMAN; INFANT; MALE; MICROSATELLITE MARKER; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION HYBRID MAPPING; SEQUENCE HOMOLOGY;

ADRENAL CORTEX NEOPLASMS; AMINO ACID SUBSTITUTION; CHILD; CHROMOSOME MAPPING; DNA MUTATIONAL ANALYSIS; GENES, P53; HETEROZYGOTE; HUMANS; INHIBINS; LOSS OF HETEROZYGOSITY; MUTATION;

EID: 2342488713     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Stratakis CA. Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony. Trends Endocrinol Metab 2003;14:404-10.
2. Ribeiro RC, Sondrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLzcerda L, Rabin M, Cadwell C, Sampaio G, Cat I, Stratokis CA, Sandrini R. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A 2001;98:9330-5.
3. Latronico AC, Pinto EM, Domenice S, Fragoso MC, Martin RM, Zerbini MC, Lucon AM, Mendonca BB. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J Clin Endocrinol Metab 2001;86:4970-3.
4. Varley JM, McGown G, Thorncroft M, Jomes LA, Margison GP, Forster G, Evans DG, Horris M, Kelsey AM, Birch JM. Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors. Am J Hum Genet 1999;65:995-1006.
5. DiGiammarino EL, Lee AS, Cadwell C, Zhang W, Bothner B, Ribeiro RC, Zambetti G, Kriwacki RW. A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nat Struct Biol 2002;9:12-6.
6. Hainaut P. Tumor-specific mutations in p53: the acid test. Nat Med 2002;8:21-3.
7. Figueiredo BC, Stratakis CA, Sandrini R, DeLacerda L, Pionovsky MA, Giatzakis C, Young HM, Haddad BR. Comparative genomic hybridization analysis of adrenocortical tumors of childhood. J Clin Endocrinol Metab 1999;84:1116-21.
8. James LA, Kelsey AM, Birch JM, Varley JM. Highly consistent genetic alterations in childhood adrenocortical tumours detected by comparative genamic hybridization. Br J Cancer 1999;81:300-4.
9. Sidhu S, Marsh DJ, Theodosopoulos G, Philips J, Bambach CP, Campbell P, Magarey CJ, Russell CF, Schulte KM, Roher HD, Delbridge L, Robinson BG. Comparative genomic hybridization analysis of adrenocortical tumors. J Clin Endocrinol Metab 2002;87:3467-74.
10. Logie A, Boulle N, Gaston V, Perin L, Boudou P, Le Bouc Y, Gicquel C. Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCl H295R cell line. J Mol Endocrinol 1999;23:23-32.
11. Wilkin F, Gagne N, Paquette J, Oligny LL, Deal C. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression. J Clin Endocrinol Metab 2000;85:2048-56.
12. Cherradi N, Bideau M, Arnaudeau S, Demaurex N, James RW, Azhar S, Capponi AM. Angiotensin II promotes selective uptake of high density lipoprotein cholesterol esters in bovine adrenal glomeruloso and human adrenocortical carcinoma cells through induction of scavenger receptor class B type I. Endocrinology 2001;142:4540-9.
13. Takahashi K, Yoshinoya A, Murokami O, Totsune K, Shibahara S. Production and secretion of two vasoactive peptides, adrenomedullin and endothelin-1, by cultured human adrenocortical carcinoma cells. Peptides 2000;21:251-6.
14. Takahashi K, Totsune K, Murakami O, Shibahara S. Expression of urotensin II and urotensin II receptor mRNAs in various human tumor cell lines and secretion of urotensin II-like immunoreactivity by SW-13 adrenocortical carcinoma cells. Peptides 2001;22:1175-9.
15. Martinerie C, Gicquel C, Loyvel A, Laurent M, Schofield PN, Le Bouc Y. Altered expression of novH is associated with human adrenocortical tumorigenesis. J Clin Endocrinol Metab 2001;86:3929-40.
16. Peri A, Luciani P, Conforti B, Boglioni-Peri S, Cioppi F, Crescioli C, Ferruzzi P, Gelmini S, Arnaldi G, Nesi G, Serb M, Montera F, Mannelli M. Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. J Clin Endocrinol Metab 2001;86:5443-9.
17. Risbridger GP, Schmitt JF, Robertson DM. Activins and inhibins in endocrine and other tumors. Endocr Rev 2001;22:830-58.
18. Mason AJ, Hayflick JS, Ling N, Esch F, Ueno N, Ying SY, Guillemin R, Niall H, Seeburg PH. Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and hamology with transforming growth factor-β. Nature (London) 1985;318:659-63.
19. Mason AJ, Niall HD, Seeburg PH. Structure of two human ovarian inhibins. Biochem Biophys Res Commun 1986;133:957-64.
20. Barton DE, Yang-Feng TL, Mason AJ, Seeburg PH, Francke U. Mapping of genes for inhibin subunits α, βA, and βB on human and mouse chromosomes and studies of jsd mice. Genomics 1989;5:91-9.
21. Matzuk MM, Finegold MJ, Mother JP, Krummen L, Lu H, Bradley A. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A 1994;91:8817-21.
22. McCluggage WG, Burton J, Maxwell P, Sloan JM. Immunohistochemical staining of normal, hyperplastic, and neaplastic adrenal cortex with a monoclonal antibody against alpha inhibin. J Clin Pathol 1998;51:114-6.
23. Vanttinen T, Kuulasmaa T, Liu J, Voutilainen R. Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells. J Clin Endocrinol Metab 2002;87:4257-63.
24. Vanttinen T, Liu J, Kuulasmaa T, Kivinen P, Voutilainen R. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocorticol steroidogenesis and apoptasis. J Endocrinol 2003;178:479-89.
25. Stratakis CA, Taymans SE, Daruwala R, Song J, Levine M. Mapping of the human genes (SLC23A2 and SLC23A1) coding for vitamin C transporters 1 and 2 (SVCT1 and SVCT2) ta 5q23 and 20p12, respectively. J Med Genet 2000;37:E20(1-3).
26. Stratakis CA, Jenkins RB, Pros E, Mitsiadis CS, Raff SB, Stalboerger PG, Tsigos C, Carney JA, Chrousos GP. Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex). J Clin Endocrinol Metab 1996;81:3607-14.
27. Cox DR, Burmeister M, Price ER, Kim S, Meyers RM. Radiation hybrid mapping: a somatic cell technique for constructing high resolution maps of mammalian chromosomes. Science 1990;250:245-50.
28. Spur NK, Bashir R, Bushby K, Cox A, Cox S, Hilde Brandt F, Hill N, Kao FT, Krols L, Marzella R, Miller N, Nothwang HG, Rocchi M, Sarfarazi M, Stratakis CA, Wollgren-Petterson C, Naylor S. Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996. Cytogenet Cell Genet 1996;73:255-73.
29. Taymans SE, Kirschner LS, Giotzakis C, Stratakis CA. Radiation hybrid mopping of chromosomal region 2p15-p16: integration of expressed and polymorphic sequences maps at the Carney complex (CNC) and Doyne honeycamb retinal dystrophy (DHRD) loci. Genomics 1999;56:344-9.
30. Xu J, McKeehan K, Matsuzaki K, McKeehan WL. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J Biol Chem 1995;270:6308-13.
31. Martens JW, de Winter JP, Timmerman MA, McLuskey A, van Schaik RH, Themmen AP, de Jong FH. Inhibin interferes with activin signalling at the level of the activin receptor complex in Chinese hamster ovary cell. Endocrinology 1997;138:2928-36.
32. Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 2000;404:411-4.
33. Stratakis CA, Chrousos GP. Adrenal cancer. Endocrinol Metab Clin North Am 2000;29:15-25.
34. Watson RH, Roy WJ Jr, Davis M, Hitchcock A, Campbell IG. Loss of heterozygosity at the alpha-inhibin locus on chromosome 2q is not a feature or human granulosa cell tumors. Gynecol Oncol 1997;65:387-90.
35. Dowling CR, Risbridger GP. The role of inhibins and activins in prostate cancer pathogenesis. Endocr Relat Cancer 2000;7:243-56.
36. Zhao J, Speel EJ, Muletta-Feurer S, Rutimann K, Saremaslani P, Roth J, Heitz PU, Komminoth P. Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis. Am J Pathol 1999;155:1039-45.